JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
KRYS - Krystal Biotech, Inc.
USD | NASDAQ | Healthcare
Summary
Summary KRYS Stock
Financials
Financials KRYS Stock
Loading...
Loading...
Income Statement
Income Statement KRYS Stock
Balance Sheet
Balance Sheet KRYS Stock
Cash Flow Statement
Cash Flow Statement KRYS Stock
Loading...
Loading...
Home
Stocks
Krystal Biotech, Inc. (KRYS)
Financials
Financials of KRYS
Loading...
Loading...
Loading...
Loading...
KRYS Financials - Krystal Biotech Income & Cash Flow | Ledgeburg
Revenue
$389.13M
Operating Income
$161.295M
Net Income
$204.831M
Share Count (Basic)
28.944M
Operating Cash Flow
$200.865M
Free Cash Flow
$188.914M
Cash And Short-Term Equivalents
$496.304M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
400M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
80M
100M
120M
Q1 FY25
Q2 FY25
Annual
Quarterly
Net Income $USD
-100M
0
100M
200M
Annual
Quarterly
Margins
Gross
Operating
Net
-200%
-150%
-100%
-50%
0%
50%
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
20M
40M
60M
80M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26